index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

120 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Treatment RNA interference Lamins Hypermobile EDS COL1A1 Calcium handling Heart failure Rare diseases AAV LGMD COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders BVES Nuclear envelope CMTX Skeletal muscle Myopathies Cancer Allele-specific silencing therapy CRISPR Biological sciences Maladies rares et orphelines Autophagosome maturation Heart Muscular dystrophy MD Mutations Cardiology Mouse Duchenne muscular dystrophy Therapy Laminopathie CSF protein Dilated cardiomyopathy Cardiomyopathy Patient registry Muscle LMNA Lamin A/C nuclei Diagnosis A-type lamin Butyrylcholinesterase Congenital muscular dystrophy Treatment delay Angiotensin-converting enzyme inhibitors Titin Connective tissue Laminopathy Muscle MRI LMNA gene Dynamin 2 Cancer biomarkers Errance diagnostique AAV VECTOR Dystrophine BiP Acetyltransferase Rare neuromuscular diseases Maladies rares Ehlers‐Danlos Syndrome Muscle biopsy Emerin COVID-19 Dystrophie musculaire Allele‐specific silencing therapy POPDC1 IPSC Angiotensin-converting enzyme inhibitor Centronuclear myopathy Lamin A/C LMNA gene Biomarker Myotubes Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS A-type lamins Adult SMA Emery-Dreifuss muscular dystrophy Regeneration Exome Neuromuscular diseases Alternative splicing COL6A1 C elegans Next generation sequencing Becker muscular dystrophy Myologie GNE C2C12 LMNA-related congenital muscular dystrophy Gene therapy Actionability Cardiac conduction system Actionable gene Myogenesis Joint laxity INPP5K Clinical trial Muscular dystrophy Myopathy Laminopathies Allele-specific silencing Lamin A/C Base de données FAIR